Literature DB >> 540333

Antiinflammatory principles of Atractylodes rhizomes.

K Endo, T Taguchi, F Taguchi, H Hikino, J Yamahara, H Fujimura.   

Abstract

Mesh：

Substances：

Year:  1979        PMID： 540333     DOI： 10.1248/cpb.27.2954

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN： 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  14 in total

1.  Analysis of mutations of two Gitelman syndrome family SLC12A3 genes and proposed treatments using Chinese medicine.

Authors:  Jie-Wei Luo; Xiao-Rong Meng; Xiao Yang; Ji-Xing Liang; Fu-Yuan Hong; Xing-Yu Zheng; Wei-Hua Li
Journal:  Chin J Integr Med       Date:  2016-01-29       Impact factor: 1.978

2.  Chemical and ecological evaluation of a genuine Chinese medicine: Atractylodes macrocephala Koidz.

Authors:  Jue Zhou; Fan Qu; Yongping Yu
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-06-01

3.  (5R,8R)-2-(3,8-Dimethyl-2-oxo-1,2,4,5,6,7,8,8a-octa-hydro-azulen-5-yl)acrylic acid (rupestonic acid).

Authors:  Haji Akber Aisa; Jian-Ping Yong; Qiao-Ying Lv; Tao Wu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-01-23

4.  Selective fraction of Atractylodes lancea (Thunb.) DC. and its growth inhibitory effect on human gastric cancer cells.

Authors:  Ming Zhao; Qingqing Wang; Zhen Ouyang; Bangxing Han; Wenbing Wang; Yuan Wei; Yan Wu; Bing Yang
Journal:  Cytotechnology       Date:  2013-04-07       Impact factor: 2.058

5.  Atractylenolide-I sensitizes human ovarian cancer cells to paclitaxel by blocking activation of TLR4/MyD88-dependent pathway.

Authors:  Jian-Ming Huang; Guo-Nan Zhang; Yu Shi; Xiao Zha; Yi Zhu; Miao-Miao Wang; Qing Lin; Wen Wang; Hai-Yan Lu; Shi-Qi Ma; Jia Cheng; Bi-Fang Deng
Journal:  Sci Rep       Date:  2014-01-23       Impact factor: 4.379

6.  Neuroprotective Role of Atractylenolide-I in an In Vitro and In Vivo Model of Parkinson's Disease.

Authors:  Sandeep More; Dong-Kug Choi
Journal:  Nutrients       Date:  2017-05-02       Impact factor: 5.717

7.  Screening for compounds with aromatase inhibiting activities from Atractylodes macrocephala Koidz.

Authors:  Hai Jiang; Jing Shi; Yuanyuan Li
Journal:  Molecules       Date:  2011-04-14       Impact factor: 4.411

8.  A randomized pilot study of atractylenolide I on gastric cancer cachexia patients.

Authors:  Yi Liu; Zhongwu Jia; Lei Dong; Rui Wang; Genquan Qiu
Journal:  Evid Based Complement Alternat Med       Date:  2008-09       Impact factor: 2.629

9.  Study on chemical fingerprinting of crude and processed Atractylodes macrocephala from different locations in Zhejiang province by reversed-phase high-performance liquid chromatography coupled with hierarchical cluster analysis.

Authors:  Hao Cai; Zhiwei Xu; Sucai Luo; Wenwen Zhang; Gang Cao; Xiao Liu; Yajing Lou; Xiaoqing Ma; Kunming Qin; Baochang Cai
Journal:  Pharmacogn Mag       Date:  2012-10       Impact factor: 1.085

10.  Atractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitro.

Authors:  Hong Liu; Guonan Zhang; Jianming Huang; Shiqi Ma; Kun Mi; Jia Cheng; Yi Zhu; Xiao Zha; Wei Huang
Journal:  J Transl Med       Date:  2016-04-27       Impact factor: 5.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.